Galileo Life Sciences Announces Name Change
Emphasizing It's Bold
Vision.
TORONTO, ONT, Canada -- March 25, 2021 -- InvestorsHub NewsWire
-- Modern Mobility Aids Inc.,
(OTC
Pink: MDRM), a company dedicated to simplifying the world of
healthcare, announced today that its Board of Directors and
shareholders voted on a new name and identity for the company:
Galileo Life Sciences, Inc. (Galileo).
"We are excited to adopt the name
Galileo Life Sciences. We believe it better reflects our objective
to make access to healthcare uncomplicated," Tito DiMarco,
President of Galileo, said.
The COVID-19 outbreak has brought
unexpected challenges to the healthcare industry. Some of these
challenges are complex. The solutions rely on the faster adaptation
of technology. Galileo's key consideration is to extend
technological capabilities to providers and
patients.
One of the major changes brought
about by the pandemic is the way patients visit their doctors. As
the corporate world turns toward digital solutions, it is
incumbent upon the medical industry to do the same. There is an
immense power in the possibilities of telehealth, and under a new
business model, Galileo plans to leverage that potential to provide
all patients with access to quality healthcare.
Galileo will not simply follow
inline using new telehealth capabilities. Just like its namesake,
the company will be a pioneer that pushes the boundaries and makes
new discoveries in this space. The famed scientist became the
inspiration for this new identity because he is known as "the
father of modern science," and Galileo will become the "father of
modern healthcare."
This new name, identity and
business model fully display the intentions of the company to be a
leader in what we expect to become a rapidly growing space.
Delivering realistic healthcare solutions to the working family is
more important than ever before. Emphasizing and committing to
telehealth is the first step to accomplishing that
mission.
For nearly two years, the company
dedicated all operations to revolutionizing the healthcare industry
and transforming it into an easily navigable space. Telehealth
brings healthcare into patients' homes. It uses technology they are
familiar with to deliver potentially life-changing medical advice.
The company is focusing its new business model, new name, and new
identity around this technology because it aligns with its vision
to provide access to quality healthcare to all.
As Galileo ventures down this
exciting new road, the company is moving full steam ahead. The name
change is effective immediately. The company expects a new ticker
symbol to be available soon.
“We also anticipate further
significant announcements in the near future,” DiMarco
concluded.
About Galileo Life
Sciences, Inc.
Galileo Life Sciences, Inc., is a
company strategically focused on the telehealth and telemedicine
industry and is planning to offer globally available services. The
company is dedicated to offering the most robust telehealth
platform incorporating AI and IOT so that everyone can get access
to quality healthcare regardless of location and financial ability.
The company is committed to providing healthcare to those who
cannot afford it. The Galileo Smart Clinics with integrated medical
devices makes the company unique and separates it from the rest of
the field. Physicians can get direct access to the patient's vitals
and examine the patient in real-time without affecting the quality
of care.
Forward-looking
Statements
This press release may contain information that may
constitute “forward-looking information” or “forward-looking
statements” within the meaning of applicable Canadian
and U.S. securities laws (collectively, “Forward-looking
Statements”). All information contained herein that is not clearly
historical in nature may constitute Forward-looking Statements. In
some cases, Forward-looking Statements can be identified by the use
of forward-looking terminology such as “may”, “will”, “expect”,
“plan”, “anticipate”, “intend”, “potential”, “estimate”, “believe”
or the negative of these terms, or other similar expressions
intended to identify Forward-looking
Statements. There are no guarantees or assurances that expansion
in leadership will result in the hopes the company has mentioned
here. Any investment made into Modern Mobility Aids, Inc., would be
classified as speculative and risky. Such risks and uncertainties
include, but are not limited to, market conditions, general
acceptance of the company’s products and technologies, competitive
factors, the ability to successfully complete additional or
adequate financing, government approvals or changes to proposed
laws and other risks and uncertainties further stated in the
company’s financial reports and filings.
Any
Forward-looking Statement included in this press release is made as
of the date of this press release and, except as required by
law, Galileo Life Sciences Inc. and Modern Mobility Aids
Inc. disclaim any obligation to update or revise any
Forward-looking Statement. Readers are cautioned not to put undue
reliance on any Forward-looking
Statement.
For further information, please
contact:
Tito
DiMarco
President,
Galileo Life
Sciences Inc.
tdimarco@mdrminc.com
Modern Mobility Aids (PK) (USOTC:MDRM)
Historical Stock Chart
From Nov 2024 to Dec 2024
Modern Mobility Aids (PK) (USOTC:MDRM)
Historical Stock Chart
From Dec 2023 to Dec 2024
